nach oben

Erschienen in:

24.09.2020 | Original Article

Neurological misdiagnoses of lymphoma

verfasst von: Chen Makranz, David Arkadir, Boaz Nachmias, Moshe E. Gatt, Ruth Eliahou, Karine Atlan, Anat Mordechai, Netta Goldshmit, Alexander Lossos

Erschienen in: Neurological Sciences | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Lymphoma of the nervous system is rare and usually involves the brain, spinal cord, or peripheral nerves. Hence, it has varied clinical presentations, and correct diagnosis is often challenging. Incorrect diagnosis delays the appropriate treatment and affects prognosis. We report 5 patients with delayed diagnosis of lymphoma involving the central and/or peripheral nervous system, initially evaluated for other neurological diagnoses. We also discuss the challenge of diagnosis and appropriate testing.

Methods

Retrospective review of 2011–2019 records of patients with confirmed nervous system lymphoma diagnosed in a tertiary care medical center.

Results

We present 5 adult patients initially evaluated for inflammatory myelopathy, inflammatory lumbosacral plexopathy, atypical parkinsonism, and demyelinating disease of the CNS. Final diagnosis of the nervous system lymphoma was delayed by 4 to 18 months and was based on tissue biopsy in 4, and on CSF and bone marrow examination in 1 patient.

Conclusions

Lymphoma may imitate various central and peripheral nervous system disorders. We suggest several red flags that indicate the need to consider lymphoma, including subacute but progressive symptomatic evolution, painful neurological deficit, unclear clinical diagnosis, and transient steroid responsiveness. Correct diagnosis often requires a combination of diagnostic tests, while pathology testing is crucial for early diagnosis and is strongly recommended in the appropriate clinical setting.

Shiels MS, Pfeiffer RM, Besson C, Clarke CA, Morton LM, Nogueira L, Pawlish K, Yanik EL, Suneja G, Engels EA (2016) Trends in primary central nervous system lymphoma incidence and survival in the U.S. Br J Haematol 174(3):417–424. https://doi.org/10.1111/bjh.14073CrossRefPubMedPubMedCentral

Grommes C, DeAngelis LM (2017) Primary CNS Lymphoma. J Clin Oncol 35(21):2410–2418. https://doi.org/10.1200/JCO.2017.72.7602CrossRefPubMedPubMedCentral

Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI (2009) Natural history of CNS relapse in patients with aggressive non-Hodgkin’s lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group. J Clin Oncol 27(1):114–119. https://doi.org/10.1200/JCO.2008.16.8021CrossRefPubMedPubMedCentral

Mead GM, Kennedy P, Smith JL, Thompson J, Macbeth FR, Ryall RD, Williams CJ, Whitehouse JM (1986) Involvement of the central nervous system by non-Hodgkin’s lymphoma in adults. A review of 36 cases. Q J Med 60(231):699–714PubMed

Ferreri AJM (2017) Secondary CNS lymphoma: the poisoned needle in the haystack. Ann Oncol 28(10):2335–2337. https://doi.org/10.1093/annonc/mdx515CrossRefPubMed

Haldorsen IS, Espeland A, Larsen JL, Mella O (2005) Diagnostic delay in primary central nervous system lymphoma. Acta Oncol 44(7):728–734. https://doi.org/10.1080/02841860500256272CrossRefPubMed

Herrlinger U, Schabet M, Clemens M, Kortmann R-D, Petersen D, Will BE, Meyemand R, Dichgans J (1998) Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand 97(4):257–264. https://doi.org/10.1111/j.1600-0404.1998.tb00647.xCrossRefPubMed

Braus DF, Schwechheimer K, Müller-Hermelink HK, Schwarzkopf G, Volk B, Mundinger F (1992) Primary cerebral malignant non-Hodgkin’s lymphomas: a retrospective clinical study. J Neurol 239(3):117–124. https://doi.org/10.1007/bf00833908CrossRefPubMed

Krough-Jensen M, Amore FD, Jensen MK, Christensen BE, Thorling K, Pedersen M, Johansen P, Boesen AM, Andersen E (1995) Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area; Population-Based Data from the Danish Lymphoma Registry, Lyfo, And the Danish Cancer Reistry. Leuk Lymphoma 19(3-4):223–233. https://doi.org/10.3109/10428199509107892CrossRef

10.

Khong P, Pitham T, Owler B (2008) Isolated neurolymphomatosis of the cauda equina and filum terminale: case report. Spine (Phila Pa 1976) 33(21):E807–E811. https://doi.org/10.1097/BRS.0b013e31818441beCrossRef

11.

Diaz-Arrastia R, Younger DS, Hair L, Inghirami G, Hays AP, Knowles DM, Odel JG, Fetell MR, Lovelace RE, Rowland LP (1992) Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology 42(6):1136–1141. https://doi.org/10.1212/wnl.42.6.1136CrossRefPubMed

12.

Avila JD, Vivar C (2017) Neurolymphomatosis: a review of 82 cases (P5.141). Neurology 88(16 Supplement)

13.

Nakashima H, Imagama S, Ito Z, Ando K, Kobayashi K, Ukai J, Muramoto A, Shinjyo R, Matsumoto T, Yamauchi I, Satou A, Ishiguro N (2014) Primary cauda equina lymphoma: case report and literature review. Nagoya J Med Sci 76(3-4):349–354PubMedPubMedCentral

14.

Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM (2011) Primary intramedullary spinal cord lymphoma. Neurology 77(8):784–791. https://doi.org/10.1212/WNL.0b013e31822b00b9CrossRefPubMed

15.

Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM (2012) Secondary intramedullary spinal cord non-Hodgkin's lymphoma. J Neuro-Oncol 107(3):575–580. https://doi.org/10.1007/s11060-011-0781-4CrossRef

16.

Cohen-Gadol AA, Zikel OM, Miller GM, Aksamit AJ, Scheithauer BW, Krauss WE (2003) Spinal Cord Biopsy: A Review of 38 Cases. Neurosurgery 52(4):806–816. https://doi.org/10.1227/01.NEU.0000053223.77641.5ECrossRefPubMed

17.

Schwarz S, Zoubaa S, Knauth M, Sommer C, Storch-Hagenlocher B (2002) Intravascular lymphomatosis presenting with a conus medullaris syndrome mimicking disseminated encephalomyelitis. Neuro-Oncology 4(3):187–191. https://doi.org/10.1093/neuonc/4.3.187CrossRefPubMedPubMedCentral

18.

Kumar N, Keegan BM, Rodriguez FJ, Hammack JE, Kantarci OH Intravascular lymphoma presenting as a longitudinally-extensive myelitis: diagnostic challenges and etiologic clues. J Neurol Sci 303(1):146–149. https://doi.org/10.1016/j.jns.2010.12.016

19.

Ali K, Morris HR (2015) Parkinson’s disease: chameleons and mimics. Pract Neurol 15(1):14–25. https://doi.org/10.1136/practneurol-2014-000849CrossRefPubMed

20.

Sanchez-Guerra M, Cerezal L, Leno C, Diez C, Figols J, Berciano J (2001) Primary brain lymphoma presenting as Parkinson’s disease. Neuroradiology 43(1):36–40CrossRef

21.

Gherardi R, Roualdes B, Fleury J, Prost C, Poirier J, Degos JD (1985) Parkinsonian syndrome and central nervous system lymphoma involving the substantia nigra. A case report. Acta Neuropathol 65(3-4):338–343CrossRef

22.

Pramstaller PP, Salerno A, Bhatia KP, Prugger M, Marsden CD (1999) Primary central nervous system lymphoma presenting with a parkinsonian syndrome of pure akinesia. J Neurol 246(10):934–938CrossRef

23.

Solomon AJ, Weinshenker BG (2013) Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep 13(12):403. https://doi.org/10.1007/s11910-013-0403-yCrossRefPubMed

24.

Rudick RA, Miller AE (2012) Multiple sclerosis or multiple possibilities: the continuing problem of misdiagnosis. Neurology 78(24):1904–1906. https://doi.org/10.1212/WNL.0b013e318259e2e2CrossRefPubMed

25.

Solomon AJ, Klein EP, Bourdette D (2012) “Undiagnosing” multiple sclerosis: the challenge of misdiagnosis in MS. Neurology 78(24):1986–1991. https://doi.org/10.1212/WNL.0b013e318259e1b2CrossRefPubMedPubMedCentral

26.

Kuker W, Nagele T, Thiel E, Weller M, Herrlinger U (2005) Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology 65(7):1129–1131. https://doi.org/10.1212/01.wnl.0000178894.51436.54CrossRefPubMed

27.

Husseini L, Saleh A, Reifenberger G, Hartung HP, Kieseier BC (2012) Inflammatory demyelinating brain lesions heralding primary CNS lymphoma. Can J Neurol Sci 39(1):6–10CrossRef

28.

Kuhlmann T, Schroter A, Dechent P, Weber F, Rustenbeck HH, Fuzesi L, Bruck W, Ehrenreich H, Frahm J (2001) Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 70(2):259–262CrossRef

29.

Lin X, Tan K, Liauw L, Tin AS, Soon W, Eileen YSR, Zhu TBP, Lee HY, Yu W-Y (2014) Distinguishing clinico-radiological features in patients with central nervous system tumefactive white matter lesions (P5.177). Neurology 82(10 Supplement)

30.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, GC DL, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J, Group MS (2018) The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol 14(4):199–213. https://doi.org/10.1038/nrneurol.2018.14CrossRefPubMed

31.

DeAngelis LM (1999) Primary central nervous system lymphoma. Curr Opin Neurol 12(6):687–691CrossRef

32.

Rubenstein J, Ferreri AJM, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma 49(sup1):43–51. https://doi.org/10.1080/10428190802311441CrossRefPubMedPubMedCentral

33.

Nowosielski M, Pardo-Moreno J, Penalver FJ, Buda G, Bennani H, Costopoulos M, Le Garff-Tavernier M, Soussain C, Schmid M, Orfao JA, Glantz M (2016) How to facilitate early diagnosis of CNS involvement in malignant lymphoma AU - Korfel, Agnieszka. Expert Rev Hematol 9(11):1081–1091. https://doi.org/10.1080/17474086.2016.1242405CrossRefPubMed

Titel: Neurological misdiagnoses of lymphoma
verfasst von: Chen Makranz
David Arkadir
Boaz Nachmias
Moshe E. Gatt
Ruth Eliahou
Karine Atlan
Anat Mordechai
Netta Goldshmit
Alexander Lossos
Publikationsdatum: 24.09.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 5/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04724-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Selective cranial multineuritis in severe COVID-19 pneumonia: two cases and literature review

Risk factors predicting recurrence of transient global amnesia

Static magnetic stimulation in the central nervous system: a systematic review

Microcytic abnormalities of the inner retina in a patient with myelin oligodendrocyte glycoprotein (MOG) antibody–associated optic neuritis

Correction to: Efficacy and acceptability of the S1P receptor in the treatment of multiple sclerosis: a meta-analysis

New MAPT variant in a FTD patient with Alzheimer’s disease phenotype at onset

Leitlinien kompakt für die Neurologie

Update Neurologie